• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconModerna

Moderna

PoliticsFDA backtracks and agrees to review Moderna mRNA flu vaccine after initial rejection
By Lauran Neergaard and The Associated PressFebruary 18, 2026
Child getting a vaccine
HealthWhat you need to know about Moderna’s new COVID vaccine, just approved by the FDA
By Beth GreenfieldJune 2, 2025
HealthTrump administration cancels $766 million contract with Moderna to develop vaccine against pandemic flu viruses
By The Associated PressMay 29, 2025
ConferencesThis Moderna leader uses AI to resolve conflict on the executive team—all before it even happens 
By Sara BraunMay 19, 2025
Robert F. Kennedy Jr. looks forward, while Donald Trump looks back at him.
FinanceModerna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’
By Sasha RogelbergMarch 31, 2025
Hens at a poultry farm
HealthExperts sound the alarm as Ohio farmworker’s bird flu sparks fear it’s the next pandemic
By Lindsey LeakeFebruary 13, 2025
Days before President Donald Trump took office a second time, the Department of Health and Human Services granted Moderna $590 million for the development of mRNA vaccines for bird flu and other influenza viruses.
HealthAs bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
By Lindsey LeakeJanuary 22, 2025
Moderna is recruiting adult participants for Nova 301, its Phase 3 clinical trial evaluating an investigational norovirus vaccine called mRNA-1403.
HealthModerna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.
By Lindsey LeakeJanuary 11, 2025
As of spring 2024, at which time two RSV vaccines had been FDA-approved, less than 25% of eligible U.S. adults 60 and older had gotten one, according to the CDC.
HealthRSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
By Lindsey LeakeOctober 4, 2024
About 47% of U.S. adults aged 50 and older said they were very or somewhat unlikely to get the new 2024–25 COVID-19 vaccine, according the University of Michigan’s National Poll on Healthy Aging.
HealthCOVID sickens older adults most severely, but less than half say they’ll get the new vaccine
By Lindsey LeakeSeptember 30, 2024
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
HealthNew COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By Lindsey LeakeAugust 29, 2024
Job seeker and recruiter during interview.
LeadershipHR experts at PwC, Hilton, and Moderna reveal 6 ways you can land a job in a cooling labor market
By Emma BurleighAugust 5, 2024
David Rubenstein
FinanceA CEO abruptly resigned from a board after leaked emails reportedly showed inappropriate influence
By Marion Halftermeyer and BloombergJuly 26, 2024
A flock of chickens inside an enclosure
HealthU.S. government will pay Moderna $176 million to develop a bird flu vaccine to stave off dairy cow epidemic
By The Associated PressJuly 2, 2024
Moderna CEO Stéphane Bancel at an event to encourage people to get updated COVID-19 booster shots on September 20, 2023 in Washington, DC.
HealthModerna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
By Sunny NagpaulMay 2, 2024
1
  • 1
  • 2
  • 3
  • 4
  • 5
...18
Most Popular
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI productivity just to keep your jobAn image of a popular article
By Orianna Rosa RoyleFebruary 27, 2026
Success
Walmart exec says U.S. workforces needs to take inspiration from China where ‘5 year-olds are learning DeepSeek’An image of a popular article
By Preston ForeFebruary 27, 2026
Commentary
'The Pitt': a masterclass display of DEI in action An image of a popular article
By Robert RabenFebruary 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.